[속보] 영국 정부, 아스트라제네카 백신 긴급 사용 승인 VIDEO: [Breaking News] Oxford-AstraZeneca Covid vaccine approved by UK regulator

Oxford-AstraZeneca Covid vaccine approved by UK regulator 

PUBLISHED WED, DEC 30 20201:57 AM ESTUPDATED WED, DEC 30 20202:45 AM EST

Matt Clinch


KEY POINTS

The coronavirus vaccine being developed by the University of Oxford and AstraZeneca has been authorized for emergency use in the U.K., marking another step in the global battle against the pandemic.


The shot is expected to be rolled out next week and would be added to the Pfizer-BioNTech vaccine which has so far been given to 600,000 people in the U.K., according to government statistics.


A Brazilian doctor voluntarily receives an injection as part of phase 3 trials of a vaccine developed by the University of Oxford and British pharmaceutical company AstraZeneca, in July 2020.

Nelson Almeida | AFP | Getty Image


 

영국 정부, 아스트라제네카 백신 긴급 사용 승인


    옥스퍼드대가 개발하고 있는 아스트라제네카 코로나 바이러스 백신이 영국에서 긴급사용 허가를 받아 세계 팬데믹과의 싸움에서 또 다른 전환점를 맞이했다.




아스트라제네카는  다음 주에 출시될 것으로 예상되며, 12월에 영국이 시작한 코로나19 면역 프로그램에 추가될 것이다. 지금까지 화이자-바이오 정부 통계에 따르면, 영국에서 60만 명의 사람들에게 NTech 백신이 제공되었다고 한다.


아스트라제네카는 성명에서 "새해 초에 백신 접종이 시작될 수 있도록" 수요일 첫 번째 접종이 시작될 것이라고 말했다.


그것은 총 1억 도스까지 공급하기 위한 영국 정부와 "1분기에 수백만 도스 공급을 목표로 한다"고 덧붙였다. 2회 주사 기준 백신으로서, 이 협정은 약 6천 6백만 명의 인구를 가진 영국에서 5천만 명까지 접종할 수 있다는 것을 의미한다.


그러나 영국 정부는 수요일에 발표한 성명에서 예방접종과 면역 공동위원회가 "필요한 2회 주사가 가능한 한 짧은 시간 안에 제공하기 보다는 위험에 처한 그룹의 많은 사람들에게 첫 번째 혜택을 주는 것이 우선되어야 한다"고 권고했다고 말했다


아스트라제네카는 한국이 1천만명분을 계약한 백신으로 도입 시기는 빨라야 내년 2~3월로 예상하고 있다.


황기철 콘페이퍼 에디터

Ki Chul Hwang Conpaper editor 




edited by kcontents


LONDON — The coronavirus vaccine being developed by the University of Oxford and AstraZeneca has been authorized for emergency use in the U.K., marking another step in the global battle against the pandemic.


The shot is expected to be rolled out next week and will be added to a Covid-19 immunization program started by Britain in December. So far, the Pfizer-BioNTech vaccine has been given to 600,000 people in the U.K., according to government statistics.


In a statement, AstraZeneca said the first doses of the vaccine were being released Wednesday “so that vaccinations may begin early in the New Year.”


It added that it “aims to supply millions of doses in the first quarter” as part of its deal with the U.K. government to supply up to 100 million doses in total. As a two-dose vaccine, the agreement means up to 50 million people in the U.K., which has a population of around 66 million, could be inoculated.


BBC.com



edited by kcontents


However, the U.K. government said in a statement Wednesday that the Joint Committee on Vaccination and Immunisation, which advises it on immunization programs, had recommended that the “priority should be to give as many people in at-risk groups their first dose, rather than providing the required two doses in as short a time as possible.”


“Everyone will still receive their second dose and this will be within 12 weeks of their first. The second dose completes the course and is important for longer term protection,” it added.


U.K. government minister Michael Gove had said Monday that the approval of the Oxford-AstraZeneca vaccine could accelerate the lifting of strict lockdowns in the country, which effectively canceled Christmas festivities for millions.


Cases have surged in London and southern England with significant pressure being placed on hospitals. A new coronavirus variant found in the U.K. is reportedly more transmissible and has led to travel restrictions for people wanting to leave the country.


View full text

https://www.bbc.co.uk/news/health-55280671




Covid-19: Oxford-AstraZeneca coronavirus vaccine approved for use in UK 

kcontents

728x90

댓글()